nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Aphasia—Methotrexate—ankylosing spondylitis	0.0178	0.0178	CcSEcCtD
Ceftibuten—Candida infection—Triamcinolone—ankylosing spondylitis	0.0167	0.0167	CcSEcCtD
Ceftibuten—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.0124	0.0124	CcSEcCtD
Ceftibuten—Irritability—Methylprednisolone—ankylosing spondylitis	0.0121	0.0121	CcSEcCtD
Ceftibuten—Hyperkinesia—Prednisone—ankylosing spondylitis	0.0121	0.0121	CcSEcCtD
Ceftibuten—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.0116	0.0116	CcSEcCtD
Ceftibuten—Melaena—Methotrexate—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Ceftibuten—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Ceftibuten—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Ceftibuten—Irritability—Betamethasone—ankylosing spondylitis	0.011	0.011	CcSEcCtD
Ceftibuten—Irritability—Dexamethasone—ankylosing spondylitis	0.011	0.011	CcSEcCtD
Ceftibuten—Vaginal infection—Methotrexate—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Ceftibuten—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.0108	0.0108	CcSEcCtD
Ceftibuten—Psychotic disorder—Prednisone—ankylosing spondylitis	0.0098	0.0098	CcSEcCtD
Ceftibuten—Haemoglobin—Prednisolone—ankylosing spondylitis	0.0096	0.0096	CcSEcCtD
Ceftibuten—Irritability—Prednisone—ankylosing spondylitis	0.00958	0.00958	CcSEcCtD
Ceftibuten—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00955	0.00955	CcSEcCtD
Ceftibuten—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00883	0.00883	CcSEcCtD
Ceftibuten—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00881	0.00881	CcSEcCtD
Ceftibuten—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00878	0.00878	CcSEcCtD
Ceftibuten—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00876	0.00876	CcSEcCtD
Ceftibuten—Neutropenia—Prednisone—ankylosing spondylitis	0.00811	0.00811	CcSEcCtD
Ceftibuten—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00801	0.00801	CcSEcCtD
Ceftibuten—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00801	0.00801	CcSEcCtD
Ceftibuten—Irritability—Methotrexate—ankylosing spondylitis	0.008	0.008	CcSEcCtD
Ceftibuten—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00797	0.00797	CcSEcCtD
Ceftibuten—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00797	0.00797	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00755	0.00755	CcSEcCtD
Ceftibuten—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00749	0.00749	CcSEcCtD
Ceftibuten—Convulsion—Prednisolone—ankylosing spondylitis	0.0072	0.0072	CcSEcCtD
Ceftibuten—Haemoglobin—Prednisone—ankylosing spondylitis	0.00698	0.00698	CcSEcCtD
Ceftibuten—Haemorrhage—Prednisone—ankylosing spondylitis	0.00694	0.00694	CcSEcCtD
Ceftibuten—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00688	0.00688	CcSEcCtD
Ceftibuten—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00679	0.00679	CcSEcCtD
Ceftibuten—Neutropenia—Methotrexate—ankylosing spondylitis	0.00678	0.00678	CcSEcCtD
Ceftibuten—Dysuria—Methotrexate—ankylosing spondylitis	0.00678	0.00678	CcSEcCtD
Ceftibuten—Convulsion—Triamcinolone—ankylosing spondylitis	0.00663	0.00663	CcSEcCtD
Ceftibuten—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00661	0.00661	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00641	0.00641	CcSEcCtD
Ceftibuten—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00637	0.00637	CcSEcCtD
Ceftibuten—Renal failure—Methotrexate—ankylosing spondylitis	0.00635	0.00635	CcSEcCtD
Ceftibuten—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00624	0.00624	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00623	0.00623	CcSEcCtD
Ceftibuten—Haematuria—Methotrexate—ankylosing spondylitis	0.00616	0.00616	CcSEcCtD
Ceftibuten—Insomnia—Prednisolone—ankylosing spondylitis	0.00614	0.00614	CcSEcCtD
Ceftibuten—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00609	0.00609	CcSEcCtD
Ceftibuten—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00603	0.00603	CcSEcCtD
Ceftibuten—Convulsion—Betamethasone—ankylosing spondylitis	0.00601	0.00601	CcSEcCtD
Ceftibuten—Convulsion—Dexamethasone—ankylosing spondylitis	0.00601	0.00601	CcSEcCtD
Ceftibuten—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00583	0.00583	CcSEcCtD
Ceftibuten—Haemorrhage—Methotrexate—ankylosing spondylitis	0.0058	0.0058	CcSEcCtD
Ceftibuten—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00566	0.00566	CcSEcCtD
Ceftibuten—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00566	0.00566	CcSEcCtD
Ceftibuten—Insomnia—Triamcinolone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Ceftibuten—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Ceftibuten—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Ceftibuten—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Ceftibuten—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00556	0.00556	CcSEcCtD
Ceftibuten—Agitation—Prednisone—ankylosing spondylitis	0.00555	0.00555	CcSEcCtD
Ceftibuten—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00549	0.00549	CcSEcCtD
Ceftibuten—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Ceftibuten—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Ceftibuten—Anorexia—Betamethasone—ankylosing spondylitis	0.0054	0.0054	CcSEcCtD
Ceftibuten—Anorexia—Dexamethasone—ankylosing spondylitis	0.0054	0.0054	CcSEcCtD
Ceftibuten—Urticaria—Prednisolone—ankylosing spondylitis	0.00539	0.00539	CcSEcCtD
Ceftibuten—Fatigue—Triamcinolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Ceftibuten—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00537	0.00537	CcSEcCtD
Ceftibuten—Convulsion—Prednisone—ankylosing spondylitis	0.00524	0.00524	CcSEcCtD
Ceftibuten—Chills—Methotrexate—ankylosing spondylitis	0.00521	0.00521	CcSEcCtD
Ceftibuten—Insomnia—Dexamethasone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Ceftibuten—Insomnia—Betamethasone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00509	0.00509	CcSEcCtD
Ceftibuten—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00508	0.00508	CcSEcCtD
Ceftibuten—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00508	0.00508	CcSEcCtD
Ceftibuten—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.005	0.005	CcSEcCtD
Ceftibuten—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Ceftibuten—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Ceftibuten—Urticaria—Triamcinolone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Ceftibuten—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Ceftibuten—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Ceftibuten—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Ceftibuten—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Ceftibuten—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Ceftibuten—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Ceftibuten—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Ceftibuten—Fatigue—Betamethasone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Ceftibuten—Fatigue—Dexamethasone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Ceftibuten—Anorexia—Prednisone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Ceftibuten—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0046	0.0046	CcSEcCtD
Ceftibuten—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Ceftibuten—Urticaria—Betamethasone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Ceftibuten—Urticaria—Dexamethasone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Ceftibuten—Dizziness—Prednisolone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Ceftibuten—Asthenia—Triamcinolone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Ceftibuten—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Ceftibuten—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Ceftibuten—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Ceftibuten—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Ceftibuten—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Ceftibuten—Insomnia—Prednisone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Ceftibuten—Paraesthesia—Prednisone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Ceftibuten—Pruritus—Triamcinolone—ankylosing spondylitis	0.00442	0.00442	CcSEcCtD
Ceftibuten—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Ceftibuten—Convulsion—Methotrexate—ankylosing spondylitis	0.00438	0.00438	CcSEcCtD
Ceftibuten—Dyspepsia—Prednisone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Ceftibuten—Decreased appetite—Prednisone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Ceftibuten—Rash—Prednisolone—ankylosing spondylitis	0.00428	0.00428	CcSEcCtD
Ceftibuten—Dermatitis—Prednisolone—ankylosing spondylitis	0.00428	0.00428	CcSEcCtD
Ceftibuten—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Ceftibuten—Fatigue—Prednisone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Ceftibuten—Headache—Prednisolone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Ceftibuten—Constipation—Prednisone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Ceftibuten—Dizziness—Triamcinolone—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Ceftibuten—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Ceftibuten—Asthenia—Dexamethasone—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Ceftibuten—Asthenia—Betamethasone—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Ceftibuten—Nausea—Prednisolone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Ceftibuten—Pruritus—Dexamethasone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Ceftibuten—Pruritus—Betamethasone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Ceftibuten—Vomiting—Triamcinolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Ceftibuten—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Ceftibuten—Rash—Triamcinolone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Ceftibuten—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Ceftibuten—Anorexia—Methotrexate—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Ceftibuten—Rash—Methylprednisolone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Ceftibuten—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Ceftibuten—Urticaria—Prednisone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Ceftibuten—Headache—Triamcinolone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Ceftibuten—Headache—Methylprednisolone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Ceftibuten—Abdominal pain—Prednisone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Ceftibuten—Body temperature increased—Prednisone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Ceftibuten—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Ceftibuten—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Ceftibuten—Dizziness—Betamethasone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Ceftibuten—Dizziness—Dexamethasone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Ceftibuten—Insomnia—Methotrexate—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Ceftibuten—Nausea—Triamcinolone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Ceftibuten—Paraesthesia—Methotrexate—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Ceftibuten—Nausea—Methylprednisolone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Ceftibuten—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Ceftibuten—Somnolence—Methotrexate—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Ceftibuten—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Ceftibuten—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Ceftibuten—Vomiting—Dexamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Ceftibuten—Vomiting—Betamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Ceftibuten—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Ceftibuten—Rash—Betamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Ceftibuten—Rash—Dexamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Ceftibuten—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Ceftibuten—Dermatitis—Betamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Ceftibuten—Fatigue—Methotrexate—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Ceftibuten—Headache—Betamethasone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Ceftibuten—Headache—Dexamethasone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Ceftibuten—Asthenia—Prednisone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Ceftibuten—Pruritus—Prednisone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Ceftibuten—Diarrhoea—Prednisone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Ceftibuten—Nausea—Dexamethasone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Ceftibuten—Nausea—Betamethasone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Ceftibuten—Urticaria—Methotrexate—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Ceftibuten—Dizziness—Prednisone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Ceftibuten—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Ceftibuten—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Ceftibuten—Vomiting—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Ceftibuten—Rash—Prednisone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Ceftibuten—Dermatitis—Prednisone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Ceftibuten—Headache—Prednisone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Ceftibuten—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Ceftibuten—Asthenia—Methotrexate—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Ceftibuten—Nausea—Prednisone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Ceftibuten—Pruritus—Methotrexate—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Ceftibuten—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Ceftibuten—Dizziness—Methotrexate—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Ceftibuten—Vomiting—Methotrexate—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Ceftibuten—Rash—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Ceftibuten—Dermatitis—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Ceftibuten—Headache—Methotrexate—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Ceftibuten—Nausea—Methotrexate—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
